Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Moore Smith

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|March 14, 2022
Advances in Hodgkin Lymphoma: Including the Patient's VoiceChristine Moore Smith, Debra L Friedman
Pediatric Blood & Cancer|March 22, 2025
Current Treatment Strategies and Supportive Care Practices in the Care of Children and Adolescents With Mature B-Cell Non-Hodgkin Lymphoma: A Survey of Children's Oncology Group InstitutionsJennifer A Belsky, Christine Moore Smith, Sarah Alexander
JCO Oncology Practice|November 22, 2019
Using Quality Improvement Methodology to Implement Survivorship Care PlansChristine Moore Smith, Debra L Friedman, Barron L Patterson
Hospital Pediatrics|April 26, 2026
Boarding Pass to Better Medication Delivery for Boarded Pediatric Emergency PatientsJessica Hayes, Christine Moore Smith, Megan Malik, et al.
Clinical Case Reports|November 29, 2023
A rare cause of posterior reversible encephalopathy syndrome: Acute lymphoblastic leukemiaJessica Hayes, Anne Byrd Mahoney, Claci Ayers, et al.
British Journal of Haematology|December 1, 2022
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborativeZeinab Afify, Manuela Orjuela-Grimm, Christine Moore Smith, et al.
Cancer|December 26, 2022
Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disordersZeinab A M Afify, Mary M Taj, Manuela Orjuela-Grimm, et al.
Blood Advances|January 22, 2025
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug eraLianna J Marks, Victor Ritter, Jennifer E Agrusa, et al.
Blood Advances|April 14, 2026
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analysesJamie E Flerlage, Dennis A Eichenauer, Michael Fuchs, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|March 14, 2022
Advances in Hodgkin Lymphoma: Including the Patient's VoiceChristine Moore Smith, Debra L Friedman
Pediatric Blood & Cancer|March 22, 2025
Current Treatment Strategies and Supportive Care Practices in the Care of Children and Adolescents With Mature B-Cell Non-Hodgkin Lymphoma: A Survey of Children's Oncology Group InstitutionsJennifer A Belsky, Christine Moore Smith, Sarah Alexander
JCO Oncology Practice|November 22, 2019
Using Quality Improvement Methodology to Implement Survivorship Care PlansChristine Moore Smith, Debra L Friedman, Barron L Patterson
Hospital Pediatrics|April 26, 2026
Boarding Pass to Better Medication Delivery for Boarded Pediatric Emergency PatientsJessica Hayes, Christine Moore Smith, Megan Malik, et al.
Clinical Case Reports|November 29, 2023
A rare cause of posterior reversible encephalopathy syndrome: Acute lymphoblastic leukemiaJessica Hayes, Anne Byrd Mahoney, Claci Ayers, et al.
British Journal of Haematology|December 1, 2022
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborativeZeinab Afify, Manuela Orjuela-Grimm, Christine Moore Smith, et al.
Cancer|December 26, 2022
Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disordersZeinab A M Afify, Mary M Taj, Manuela Orjuela-Grimm, et al.
Blood Advances|January 22, 2025
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug eraLianna J Marks, Victor Ritter, Jennifer E Agrusa, et al.
Blood Advances|April 14, 2026
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analysesJamie E Flerlage, Dennis A Eichenauer, Michael Fuchs, et al.
Pageof 1